Table 3.
Comparison of perceived risk and awareness by age group.
| Variable | Age group (n1, n2) | No-intention | Intention | p Value |
|---|---|---|---|---|
| Perceived risk a | n1 | n2 | ||
| Lifetime perceived risk of HIV acquisition (1–5) | 18–24 (n1 = 434, n2 = 42) | 1.7 ± 0.7 | 1.6 ± 0.8 | 0.79 |
| 25–34 (n1 = 507, n2 = 55) | 1.6 ± 0.7 | 1.6 ± 0.5 | 0.97 | |
| 35–44 (n1 = 114, n2 = 18) | 1.7 ± 0.6 | 1.6 ± 0.8 | 0.77 | |
| 45–54 (n1 = 56, n2 = 5) | 1.5 ± 0.8 | 2.2 ± 0.4 | 0.06 | |
| 55+ (n1 = 35, n2 = 7) | 1.7 ± 0.7 | 1.3 ± 0.5 | 0.20 | |
| Perceived risk of HIV acquisition in next 12 months (1–5) | 18–24 (n1 = 432, n2 = 42) | 1.4 ± 0.6 | 1.4 ± 0.7 | 0.88 |
| 25–34 (n1 = 508, n2 = 54) | 1.4 ± 0.6 | 1.3 ± 0.5 | 0.48 | |
| 35–44 (n1 = 115, n2 = 18) | 1.5 ± 0.6 | 1.6 ± 0.6 | 0.29 | |
| 45–54 (n1 = 57, n2 = 5) | 1.3 ± 0.7 | 1.6 ± 0.9 | 0.39 | |
| 55+ (n1 = 33, n2 = 7) | 1.5 ± 0.8 | 1.3 ± 0.5 | 0.53 | |
| Awareness a | ||||
| Heard of people who do not have HIV taking PrEP to reduce the risk of getting HIV | 18–24 (n1 = 427, n2 = 42) | 170 (39.8) | 17 (40.5) | >0.99 |
| 25–34 (n1 = 516, n2 = 54) | 224 (43.4) | 21 (38.9) | 0.57 | |
| 35–44 (n1 = 118, n2 = 17) | 45 (38.1) | 12 (70.6) | 0.02 | |
| 45–54 (n1 = 57, n2 = 4) | 21 (36.8) | 1 (25.0) | >0.99 | |
| 55+ (n1 = 34, n2 = 7) | 13 (38.2) | 2 (28.6) | >0.99 | |
| Heard about PrEP from Doctor | 18–24 (n1 = 170, n2 = 17) | 46 (27.1) | 8 (47.1) | 0.10 |
| 25–34 (n1 = 224, n2 = 21) | 55 (24.6) | 11 (52.4) | 0.01 | |
| 35–44 (n1 = 45, n2 = 12) | 7 (15.6) | 7 (58.3) | <0.01 | |
| 45–54 (n1 = 21, n2 = 1) | 6 (28.6) | 0 (0) | >0.99 | |
| 55+ (n1 = 13, n2 = 2) | 3 (23.1) | 0 (0) | >0.99 | |
| Discussion with a healthcare provider about taking PrEP in the past 12 months | 18–24 (n1 = 170, n2 = 16) | 29 (17.1) | 6 (37.5) | 0.09 |
| 25–34 (n1 = 224, n2 = 21) | 47 (21.0) | 11 (52.4) | <0.01 | |
| 35–44 (n1 = 44, n2 = 12) | 7 (15.9) | 7 (58.3) | <0.01 | |
| 45–54 (n1 = 21, n2 = 1) | 7 (33.3) | 1 (100) | 0.36 | |
| 55+ (n1 = 13, n2 = 2) | 3 (23.1) | 2 (100) | 0.10 | |
| Received PrEP or a PrEP prescription in the past 12 months | 18–24 (n1 = 29, n2 = 6) | 3 (10.3) | 5 (83.3) | <0.01 |
| 25–34 (n1 = 47, n2 = 11) | 4 (8.5) | 8 (72.7) | <0.01 | |
| 35–44 (n1 = 7, n2 = 7) | 3 (42.9) | 5 (71.4) | 0.59 | |
| 45–54 (n1 = 7, n2 = 1) | 2 (28.6) | 0 (0) | >0.99 | |
| 55+ (n1 = 3, n2 = 2) | 2 (66.7) | 2 (100) | >0.99 |
a
Categorical data are presented as n(% of participants n represents within each age group). The n1, n2 in the second column indicates the number of subjects answering the question without intention and with intention to use PrEP, respectively.
PrEP, Pre-exposure prophylaxis.